Sign in Request access
Sign inRequest access
OpenTender 30 Nov 2026, 23:58 (UTC+01:00)

Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

At a glance

Techniker Krankenkasse is procuring Pharmaceutical products (CPV 33600000) in Hamburg (DE600). The notice gives 30 November 2026, 23:58 (UTC+01:00) as the deadline. Procedure type: Open.

From the notice

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Biologika-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 12 Monate beginnend mit dem 01.12.2025. Der Vertrag endet spätestens am 30.11.2026, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Key facts

Each fact is from the official notice, last checked 12 November 2026, 10:30 (UTC+01:00).

Status
OpenOfficial notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Deadline
(in 18 days)Official notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Buyer
Techniker Krankenkasse, Hamburg, DEOfficial notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Place of performance
Hamburg (DE600)Official notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Procedure
OpenOfficial notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
Lots
1Official notice · checked 12 Nov 2026, 10:30 (UTC+01:00)
First published
4 June 2026, 14:56 (UTC+02:00)Official notice · checked 12 Nov 2026, 10:30 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) — Techniker Krankenkasse, deadline 30 November 2026, 23:58 (UTC+01:00). A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

    Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) im Rahmen eines Open-House-Verfahrens.

    CPV
    Pharmaceutical products (CPV 33600000)
    Place
    Hamburg (DE600)
    Deadline

Timeline

  1. 4 June 2026, 14:56 (UTC+02:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice

Buyer and place

Buyer

Techniker Krankenkasse
Hamburg, DE

Place of performance

  • Hamburg (DE600)

Classification

CPV codes

  • 33600000: Pharmaceutical products

NUTS regions

  • DE600: Hamburg

Official documents

Links go to the publisher. Inteliwert does not copy the documents.

Questions and answers

When is the deadline?

The official notice gives 30 November 2026, 23:58 (UTC+01:00) as the deadline.

Who is the buyer?

Techniker Krankenkasse, Hamburg, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Where is the work performed (NUTS)?

Hamburg (DE600).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Open.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
Bekanntmachungsservice
Licence
CC0 1.0
Last checked
12 November 2026, 10:30 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version